Gene: PEX5
Official Full Name: peroxisomal biogenesis factor 5provided by HGNC
Gene Summary: The product of this gene binds to the C-terminal PTS1-type tripeptide peroxisomal targeting signal (SKL-type) and plays an essential role in peroxisomal protein import. Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of neonatal adrenoleukodystrophy (NALD), a cause of Zellweger syndrome (ZWS) as well as may be a cause of infantile Refsum disease (IRD). Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09451 | PEX5 Knockout cell line (HeLa) | Human | PEX5 | 1:3~1:6 | Negative | Online Inquiry |
KO09452 | PEX5 Knockout cell line (HCT 116) | Human | PEX5 | 1:2~1:4 | Negative | Online Inquiry |
KO09453 | PEX5 Knockout cell line (HEK293) | Human | PEX5 | 1:3~1:6 | Negative | Online Inquiry |
KO09454 | PEX5 Knockout cell line (A549) | Human | PEX5 | 1:3~1:4 | Negative | Online Inquiry |
PEX5 Gene Knockout Cell Lines are genetically modified cell lines that have been precisely engineered to disrupt the expression of the PEX5 gene, which is critical for peroxisome biogenesis. Peroxisomes play a vital role in fatty acid metabolism and the detoxification of reactive oxygen species, and PEX5 is responsible for the import of peroxisomal matrix proteins that facilitate these functions. By employing advanced CRISPR-Cas9 gene editing techniques, these knockout cell lines provide researchers with a powerful model to study the consequences of disrupted peroxisome function, enabling investigations into various metabolic disorders and related diseases.
The key function of PEX5 Gene Knockout Cell Lines lies in their ability to mimic pathological conditions associated with peroxisomal dysfunction. Researchers can observe alterations in metabolic pathways, changes in cellular morphology, and the progression of disease phenotypes, enhancing our understanding of peroxisomal disorders such as Zellweger syndrome, X-linked adrenoleukodystrophy, and other inherited metabolic diseases. These cell lines serve as essential tools in drug discovery, therapeutic strategy development, and the assessment of potential gene therapies.
One of the significant advantages of PEX5 Gene Knockout Cell Lines is their specificity and reliability, allowing researchers to obtain reproducible results that are directly attributable to PEX5 disruption. Compared to alternative models, such as whole-animal studies or less-targeted methods of gene disruption, these cell lines provide streamlined experimental setups with fewer confounding variables. Furthermore, their use facilitates high-throughput screening processes, which is beneficial for collaborative research and pharmaceutical development.
For researchers and clinicians investigating metabolic diseases, PEX5 Gene Knockout Cell Lines represent an invaluable asset, offering an in-depth understanding of peroxisomal function and its implications in human health. These cell lines not only contribute to advancing scientific knowledge but also pave the way for innovative therapeutic approaches.
[Your Company Name] has a proven track record in developing high-quality biological products and genetic tools, ensuring that PEX5 Gene Knockout Cell Lines are created with precision and rigor by a team of experts committed to supporting your research and clinical endeavors. Your success in unlocking the complexities of peroxisomal disorders begins with our specialized products that meet the highest standards of scientific excellence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.